Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» DMD
DMD
Capricor’s cell therapy shows three year benefit in DMD patients
Clinical Trials Arena
Mon, 07/1/24 - 11:13 am
Capricor
deramiocel
cell therapy
DMD
clinical trials
After full approval, Sarepta lays out its next moves
BioSpace
Wed, 06/26/24 - 11:31 am
Sarepta Therapeutics
DMD
Elevidys
gene therapy
Sarepta Duchenne gene therapy wins broader use from FDA
BioPharma Dive
Thu, 06/20/24 - 06:09 pm
Sarepta Therapeutics
gene therapy
FDA
DMD
Elevidys
Pfizer setback brings questions for Duchenne gene therapy ahead of Sarepta decision
BioPharma Dive
Thu, 06/13/24 - 11:07 pm
Pfizer
DMD
gene therapy
FDA
Sarepta Therapeutics
Elevidys
Pfizer gene therapy for Duchenne fails to meet goals of key trial
BioPharma Dive
Wed, 06/12/24 - 11:32 pm
Pfizer
Duchenne Muscular Dystrophy
DMD
clinical trials
Ciffreo
Nippon Shinyaku’s DMD drug fails confirmatory trial
Pharmaphorum
Tue, 05/28/24 - 10:42 am
Nippon Shinyaku
DMD
Viltepso
clinical trials
Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapy
BioSpace
Wed, 05/8/24 - 11:13 am
Sarepta Therapeutics
DMD
Elevidys
gene therapy
Patient dies in Pfizer study of Duchenne gene therapy
BioPharma Dive
Tue, 05/7/24 - 06:32 pm
Pfizer
DMD
fordadistrogene movaparvovec
clinical trials
patient deaths
5 DMD Data Readouts to Watch in 2024
BioSpace
Mon, 05/6/24 - 11:24 am
DMD
clinical trials
Pfizer
gene therapy
fordadistrogene movaparvovec
Dyne Therapeutics
DYNE-251
Edgewise Therapeutics
EDG-5506
Capricor
CAP-1002
Avidity Biosciences
AOC 1044
FDA’s Accelerated Approval of Sarepta DMD Gene Therapy Comes Under Fire
BioSpace
Fri, 05/3/24 - 11:20 am
FDA
accelerated approvals
Sarepta Therapeutics
DMD
gene therapy
FDA approves Italfarmaco’s Duvyzat for DMD treatment
Pharmaceutical Business Review
Fri, 03/22/24 - 09:38 am
Italfarmaco
FDA
Duvyzat
DMD
Duchenne Muscular Dystrophy
Regenxbio data suggest ‘niche’ in Duchenne gene therapy
BioPharma Dive
Thu, 03/7/24 - 11:05 am
Regenxbio
Duchenne Muscular Dystrophy
DMD
RGX-202
Sarepta Therapeutics
Elevidys
Sarepta's next DMD drug seems to get the job done, but Elevidys casts long shadow
Fierce Biotech
Mon, 01/29/24 - 10:25 pm
Sarepta Therapeutics
DMD
SRP-5051
Elevidys
PTC's re-examination bid for DMD drug Translarna falls short in Europe
Fierce Pharma
Fri, 01/26/24 - 11:10 am
PTC Therapeutics
EMA
Europe
Translarna
DMD
Santhera debuts DMD drug Agamree in Germany
Pharmaphorum
Mon, 01/15/24 - 09:37 am
Santhera
Duchenne Muscular Dystrophy
DMD
Agamree
Germany
Sarepta enjoys early sales ramp for DMD gene therapy, maintains confidence in label expansion
Fierce Pharma
Thu, 11/2/23 - 05:15 pm
Sarepta Therapeutics
DMD
Duchenne Muscular Dystrophy
Elevidys
gene therapy
Sarepta’s disappointing data put the FDA in a difficult spot
Stat
Tue, 10/31/23 - 10:16 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
DMD
FDA
gene therapy
FDA Approves Novel Corticosteroid Treatment Option for DMD Patients
BioSpace
Fri, 10/27/23 - 11:47 am
Santhera Pharmaceuticals
Catalyst Pharmaceuticals
Agamree
FDA
DMD
Duchenne Muscular Dystrophy
Santhera closes on first approval for DMD drug vamorolone
Pharmaphorum
Fri, 10/13/23 - 10:23 am
Santhera
Duchenne Muscular Dystrophy
DMD
vamorolone
EMA
PTC deepens layoffs as DMD drug faces loss of authorization across Europe
Fierce Biotech
Fri, 09/29/23 - 10:19 am
PTC Therapeutics
DMD
layoffs
Europe
Translarna
Pages
1
2
3
next ›
last »